AIM ImmunoTech (AIM) Change in Acquisitions & Divestments (2010 - 2026)
AIM ImmunoTech's (AIM) quarterly Change in Acquisitions & Divestments came in at $4000.0 in Q1 2026, down 99.62% YoY from $1.0 million in Q1 2025, and down 98.65% on a QoQ basis from $296000.0 in Q3 2025.
AIM ImmunoTech (AIM) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
AIM ImmunoTech (AIM) has 16 years of Change in Acquisitions & Divestments data on file, last reported at $4000.0 in Q1 2026.
- Quarterly Change in Acquisitions & Divestments fell 99.62% year-over-year to $4000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 80.64% YoY) and the FY2025 annual result came in at $2.3 million, down 58.71% from the prior year.
- Change in Acquisitions & Divestments fell to $4000.0 in Q1 2026, from $296000.0 in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $8.3 million in Q2 2022 to a low of $4000.0 in Q1 2026.
- A 5-year average of $1.4 million and a median of $598000.0 in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments surged 2049.77% — and 2026, when it slumped 99.62%.
- Tracing AIM's Change in Acquisitions & Divestments over 5 years: stood at $1.0 million in 2022, then sank by 40.26% to $598000.0 in 2023, then surged by 573.24% to $4.0 million in 2024, then tumbled by 92.65% to $296000.0 in 2025, then sank by 98.65% to $4000.0 in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $4000.0 (Q1 2026), $296000.0 (Q3 2025), and $981000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | AIM ImmunoTech | 4.43 Mn | -5.53 Mn | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Sep 30, 2025 | 296,000.00 |
| Sep 30, 2025 | 296,000.00 |
| Jun 30, 2025 | 981,000.00 |
| Jun 30, 2025 | 981,000.00 |
| Mar 31, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Sep 30, 2024 | 492,000.00 |
| Sep 30, 2024 | 492,000.00 |
| Jun 30, 2024 | 1.06 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2023 | 598,000.00 |
| Mar 31, 2023 | 598,000.00 |
| Dec 31, 2022 | 1.00 Mn |
| Dec 31, 2022 | 1.00 Mn |